Login / Signup

The difficulty in interpreting gene expression profiling in BAP-negative melanocytic tumors.

Andrew S FischerWhitney A High
Published in: Journal of cutaneous pathology (2018)
BAP-negative melanocytic tumors remain a diagnostic dilemma for dermatopathologists. A widely marketed 23-GEP test may not be useful in distinguishing these tumors from spitzoid melanoma, at least in comparison to aCGH technology.
Keyphrases
  • gene expression
  • dna methylation